Here, we provided relevant evidence indicating that OSBP2 is a hallmark of malignancy, offered strong data showing that it regulates EMT through novel mechanisms and highlighted its potential as a marker for stratifying pancreatic cancer patient. This evidence concerns the gene OSBP2 and familial pancreatic carcinoma.